Aton (ENXTPA: ALTAO)
Health Care · Biotechnology · FR
€0.01
-5.56% today · +34.2% 1Y
Aton (ENXTPA: ALTAO) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.46M and employs 13 people.
Over the last twelve months the share price has gained 34.2%, trading between 0.01 and 0.03.
Tweenvest scores Aton across four factors: quality 33/100, value 28/100. Its strongest factor is quality.
ALTAO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.46M
- Revenue (TTM)
- $776.10K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.82
- 52-week high
- €0.03
- 52-week low
- €0.01
- Avg volume (3M)
- —
- Shares outstanding
- 828.12M
- Employees
- 13
- Next earnings
- —
About Aton
Based in France, Aton operates as a bioscience enterprise, with its headquarters located in Strasbourg. Established in 1998, the company's extensive operations encompass pharmaceutical research and development, the provision of preclinical and clinical services, and the creation of monoclonal antibodies. Additionally, Aton manufactures laboratory equipment, designs and produces various medical devices—including specialized surgical instruments powered by Stemcis technology—and supplies human tissues.
- ISIN
- FR0004153930
- Founded
- 1998
- Listed since
- Dec 21, 2007
- Exchange
- Euronext Paris
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nextage Therapeutics LtdTASE: NXTG | $9.54M | ₪0.37 | -3.95% |
| Solvonis Therapeutics plcLSE: SVNS | $9.53M | £0.00 | -4.76% |
| CRISM Therapeutics CorporationAIM: CRTX | $9.51M | £0.09 | -2.70% |
| PeopleBio, Inc.KOSDAQ: A304840 | $9.47M | ₩— | — |
| Lisata Therapeutics, Inc.NasdaqCM: LSTA | $9.28M | $1.03 | -2.83% |
| Celestra Inc.KOSDAQ: A352770 | $9.28M | ₩— | — |
| Cambium Bio LimitedASX: CMB | $9.22M | AU$0.45 | -16.67% |
| Spago Nanomedical AB (publ)OM: SPAGO | $9.19M | Skr0.11 | +12.32% |
Figures last refreshed Oct 18, 2026.